S, G., B, J., X, C., M, H., TK, E., D, R., . . . SM, T. (2025). A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(8), 1427. https://doi.org/10.1158/1078-0432.CCR-24-2647
Παραπομπή σε μορφή Chicago (17η εκδ.)S, Goel, et al. "A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 8 (2025): 1427. https://doi.org/10.1158/1078-0432.CCR-24-2647.
Παραπομπή σε μορφή MLA (9th εκδ.)S, Goel, et al. "A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 8, 2025, p. 1427, https://doi.org/10.1158/1078-0432.CCR-24-2647.